Axa Cuts Position in HCA Healthcare Inc (HCA)
Axa lowered its position in shares of HCA Healthcare Inc (NYSE:HCA) by 36.8% during the fourth quarter, HoldingsChannel.com reports. The firm owned 150,800 shares of the company’s stock after selling 87,900 shares during the period. Axa’s holdings in HCA Healthcare were worth $13,247,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently bought and sold shares of HCA. Bronfman E.L. Rothschild L.P. raised its stake in shares of HCA Healthcare by 108.0% during the fourth quarter. Bronfman E.L. Rothschild L.P. now owns 2,425 shares of the company’s stock valued at $213,000 after purchasing an additional 1,259 shares during the period. Kovack Advisors Inc. purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $234,000. Financial Counselors Inc. purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $243,000. Massey Quick Simon & CO. LLC purchased a new stake in shares of HCA Healthcare during the third quarter valued at approximately $251,000. Finally, Buckley Wealth Management LLC purchased a new stake in shares of HCA Healthcare during the fourth quarter valued at approximately $264,000. Institutional investors own 72.55% of the company’s stock.
A number of analysts have recently issued reports on HCA shares. William Blair reiterated a “market perform” rating on shares of HCA Healthcare in a research note on Tuesday, November 21st. JPMorgan Chase & Co. upgraded shares of HCA Healthcare from a “neutral” rating to an “overweight” rating in a research note on Thursday, November 30th. ValuEngine upgraded shares of HCA Healthcare from a “hold” rating to a “buy” rating in a research note on Thursday, November 30th. Citigroup upgraded shares of HCA Healthcare from a “neutral” rating to a “buy” rating in a research note on Tuesday, December 12th. Finally, Zacks Investment Research upgraded shares of HCA Healthcare from a “strong sell” rating to a “hold” rating in a research note on Tuesday, December 19th. Three analysts have rated the stock with a sell rating, six have assigned a hold rating and eighteen have issued a buy rating to the company’s stock. HCA Healthcare has a consensus rating of “Buy” and a consensus price target of $104.50.
HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, January 30th. The company reported $2.12 earnings per share for the quarter, topping analysts’ consensus estimates of $1.87 by $0.25. HCA Healthcare had a net margin of 4.89% and a negative return on equity of 49.49%. The business had revenue of $11.56 billion during the quarter, compared to the consensus estimate of $11.19 billion. During the same quarter last year, the company earned $1.80 earnings per share. The business’s quarterly revenue was up 8.7% compared to the same quarter last year. research analysts expect that HCA Healthcare Inc will post 8.71 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 30th. Shareholders of record on Thursday, March 1st will be issued a $0.35 dividend. This represents a $1.40 dividend on an annualized basis and a yield of 1.35%. The ex-dividend date is Wednesday, February 28th. HCA Healthcare’s dividend payout ratio is presently 23.57%.
In other HCA Healthcare news, SVP Joseph A. Sowell III sold 58,175 shares of HCA Healthcare stock in a transaction on Friday, January 26th. The shares were sold at an average price of $95.00, for a total value of $5,526,625.00. Following the completion of the transaction, the senior vice president now owns 40,536 shares of the company’s stock, valued at $3,850,920. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Charles J. Hall sold 35,949 shares of HCA Healthcare stock in a transaction on Thursday, February 1st. The stock was sold at an average price of $103.09, for a total transaction of $3,705,982.41. Following the completion of the transaction, the insider now directly owns 111,237 shares of the company’s stock, valued at approximately $11,467,422.33. The disclosure for this sale can be found here. In the last ninety days, insiders sold 482,318 shares of company stock valued at $48,394,005. 2.90% of the stock is currently owned by corporate insiders.
TRADEMARK VIOLATION NOTICE: This piece was reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another site, it was illegally stolen and reposted in violation of U.S. and international copyright law. The legal version of this piece can be read at https://www.thecerbatgem.com/2018/03/11/axa-cuts-position-in-hca-healthcare-inc-hca.html.
HCA Healthcare Profile
HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.